These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 8940298)
21. Cell-specific inhibition of retinoic acid receptor-alpha silencing by the AF2/tau c activation domain can be overcome by the corepressor SMRT, but not by N-CoR. Baniahmad A; Dressel U; Renkawitz R Mol Endocrinol; 1998 Apr; 12(4):504-12. PubMed ID: 9544986 [TBL] [Abstract][Full Text] [Related]
22. Two basic amino acids C-terminal of the proximal box specify functional binding of the vitamin D receptor to its rat osteocalcin deoxyribonucleic acid-responsive element. Hsieh JC; Whitfield GK; Jurutka PW; Haussler CA; Thatcher ML; Thompson PD; Dang HT; Galligan MA; Oza AK; Haussler MR Endocrinology; 2003 Nov; 144(11):5065-80. PubMed ID: 12960019 [TBL] [Abstract][Full Text] [Related]
23. Role of aspartate 351 in transactivation and active conformation of estrogen receptor alpha. Kim JH; Lee MH; Kim BJ; Kim JH; Han SJ; Kim HY; Stallcup MR J Mol Endocrinol; 2005 Dec; 35(3):449-64. PubMed ID: 16326832 [TBL] [Abstract][Full Text] [Related]
24. A highly conserved region in the hormone-binding domain of the human vitamin D receptor contains residues vital for heterodimerization with retinoid X receptor and for transcriptional activation. Whitfield GK; Hsieh JC; Nakajima S; MacDonald PN; Thompson PD; Jurutka PW; Haussler CA; Haussler MR Mol Endocrinol; 1995 Sep; 9(9):1166-79. PubMed ID: 7491109 [TBL] [Abstract][Full Text] [Related]
25. A mutation mimicking ligand-induced conformational change yields a constitutive RXR that senses allosteric effects in heterodimers. Vivat V; Zechel C; Wurtz JM; Bourguet W; Kagechika H; Umemiya H; Shudo K; Moras D; Gronemeyer H; Chambon P EMBO J; 1997 Sep; 16(18):5697-709. PubMed ID: 9312028 [TBL] [Abstract][Full Text] [Related]
26. The yeast Ada complex mediates the ligand-dependent activation function AF-2 of retinoid X and estrogen receptors. vom Baur E; Harbers M; Um SJ; Benecke A; Chambon P; Losson R Genes Dev; 1998 May; 12(9):1278-89. PubMed ID: 9573045 [TBL] [Abstract][Full Text] [Related]
27. The analysis of chimeric human/rainbow trout estrogen receptors reveals amino acid residues outside of P- and D-boxes important for the transactivation function. Petit FG; Valotaire Y; Pakdel F Nucleic Acids Res; 2000 Jul; 28(14):2634-42. PubMed ID: 10908317 [TBL] [Abstract][Full Text] [Related]
28. H11-H12 loop retinoic acid receptor mutants exhibit distinct trans-activating and trans-repressing activities in the presence of natural or synthetic retinoids. Lefebvre B; Mouchon A; Formstecher P; Lefebvre P Biochemistry; 1998 Jun; 37(26):9240-9. PubMed ID: 9649304 [TBL] [Abstract][Full Text] [Related]
29. The novel co-activator CRABPII binds to RARalpha and RXRalpha via two nuclear receptor interacting domains and does not require the AF-2 'core'. Bastie JN; Despouy G; Balitrand N; Rochette-Egly C; Chomienne C; Delva L FEBS Lett; 2001 Oct; 507(1):67-73. PubMed ID: 11682061 [TBL] [Abstract][Full Text] [Related]
30. Amino-terminal protein-protein interaction motif (POZ-domain) is responsible for activities of the promyelocytic leukemia zinc finger-retinoic acid receptor-alpha fusion protein. Dong S; Zhu J; Reid A; Strutt P; Guidez F; Zhong HJ; Wang ZY; Licht J; Waxman S; Chomienne C; Chen Z; Zelent A; Chen SJ Proc Natl Acad Sci U S A; 1996 Apr; 93(8):3624-9. PubMed ID: 8622986 [TBL] [Abstract][Full Text] [Related]
31. Structure-function analysis of the Rev-erbA and RVR ligand-binding domains reveals a large hydrophobic surface that mediates corepressor binding and a ligand cavity occupied by side chains. Renaud JP; Harris JM; Downes M; Burke LJ; Muscat GE Mol Endocrinol; 2000 May; 14(5):700-17. PubMed ID: 10809233 [TBL] [Abstract][Full Text] [Related]
32. Human TAF(II)135 potentiates transcriptional activation by the AF-2s of the retinoic acid, vitamin D3, and thyroid hormone receptors in mammalian cells. Mengus G; May M; Carré L; Chambon P; Davidson I Genes Dev; 1997 Jun; 11(11):1381-95. PubMed ID: 9192867 [TBL] [Abstract][Full Text] [Related]
33. Characterization of the AB (AF-1) region in the muscle-specific retinoid X receptor-gamma: evidence that the AF-1 region functions in a cell-specific manner. Dowhan DH; Muscat GE Nucleic Acids Res; 1996 Jan; 24(2):264-71. PubMed ID: 8628649 [TBL] [Abstract][Full Text] [Related]
34. Mutational analysis of the androgen receptor AF-2 (activation function 2) core domain reveals functional and mechanistic differences of conserved residues compared with other nuclear receptors. Slagsvold T; Kraus I; Bentzen T; Palvimo J; Saatcioglu F Mol Endocrinol; 2000 Oct; 14(10):1603-17. PubMed ID: 11043576 [TBL] [Abstract][Full Text] [Related]
35. Phosphorylation of the retinoic acid receptor-alpha by protein kinase A. Rochette-Egly C; Oulad-Abdelghani M; Staub A; Pfister V; Scheuer I; Chambon P; Gaub MP Mol Endocrinol; 1995 Jul; 9(7):860-71. PubMed ID: 7476969 [TBL] [Abstract][Full Text] [Related]
36. Two distinct nuclear receptor interaction domains in NSD1, a novel SET protein that exhibits characteristics of both corepressors and coactivators. Huang N; vom Baur E; Garnier JM; Lerouge T; Vonesch JL; Lutz Y; Chambon P; Losson R EMBO J; 1998 Jun; 17(12):3398-412. PubMed ID: 9628876 [TBL] [Abstract][Full Text] [Related]
37. Ligand-dependent interaction of nuclear receptors with potential transcriptional intermediary factors (mediators). Le Douarin B; vom Baur E; Zechel C; Heery D; Heine M; Vivat V; Gronemeyer H; Losson R; Chambon P Philos Trans R Soc Lond B Biol Sci; 1996 Apr; 351(1339):569-78. PubMed ID: 8735280 [TBL] [Abstract][Full Text] [Related]
38. A four-amino-acid insertion in the ligand-binding domain inactivates hRXRbeta and renders dominant negative activity. Mahajna J; Shi B; Bruskin A DNA Cell Biol; 1997 Apr; 16(4):463-76. PubMed ID: 9150434 [TBL] [Abstract][Full Text] [Related]
39. Identification of amino acids critical for the DNA binding and dimerization properties of the human retinoic acid receptor alpha. Importance of lysine 360, lysine 365, and valine 361. Rachez C; Sautière P; Formstecher P; Lefebvre P J Biol Chem; 1996 Jul; 271(30):17996-8006. PubMed ID: 8663386 [TBL] [Abstract][Full Text] [Related]
40. The carboxy-terminal F domain of the human estrogen receptor: role in the transcriptional activity of the receptor and the effectiveness of antiestrogens as estrogen antagonists. Montano MM; Müller V; Trobaugh A; Katzenellenbogen BS Mol Endocrinol; 1995 Jul; 9(7):814-25. PubMed ID: 7476965 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]